• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用过氧乙酸对亚毫米直径血管支架进行去细胞处理。

Decellularization of submillimeter-diameter vascular scaffolds using peracetic acid.

作者信息

Yamanaka Hiroki, Morimoto Naoki, Yamaoka Tetsuji

机构信息

Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-Shinmachi, Suita, Osaka, 564-8565, Japan.

Department of Plastic and Reconstructive Surgery, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.

出版信息

J Artif Organs. 2020 Jun;23(2):156-162. doi: 10.1007/s10047-019-01152-0. Epub 2020 Jan 1.

DOI:10.1007/s10047-019-01152-0
PMID:31894445
Abstract

Various decellularization methods for allogenic and xenogenic bioscaffolds have been previously reported; however, decellularization methods for very thin (submillimeter-diameter) vascular tissues have not been discussed well. In this study, rat tail arteries (inner diameter, 0.6 mm) were decellularized with peracetic acid (PAA) and DNase I. PAA treatment is expected not only to disrupt cell membranes which improves the decellularization efficiency in the subsequent DNase treatment, but also to sterilize vascular scaffolds. We succeeded in adequate cell removal by immersing in 0.3% isotonic PAA solution and subsequent washing with DNase solution. For the DNase washing process, the perfusion method was superior in terms of cell removal to the static immersion method. Graft lumen was modified with a peptide composed of a collagen binding sequence and endothelial progenitor cell-binding sequence, (Pro-Hyp-Gly)-Gly-Gly-Gly-Arg-Glu-Asp-Val, as previously reported. They were patent in rat allogeneic transplantation model for 2 weeks, but unexpectedly resulted in graft rupture or tear formation, thereafter, suggesting reduced mechanical strength of the decellularized scaffolds. Histology showed that the thickness of the extracellular matrix (ECM) was decreased by the perfusion of the DNase solution. The method of combination of PAA and DNase was not necessarily optimal for the decellularization of very thin vascular tissues. The decellularization method is a compromise between effective cell removal and maintenance of the ECM nature. Since the acceptability of ECM denaturation by the host tissue highly depends on individual cases, decellularization methods should be carefully selected according to the type of target tissue and its intended use.

摘要

此前已有多种用于同种异体和异种生物支架的脱细胞方法的报道;然而,针对非常细(直径亚毫米级)的血管组织的脱细胞方法尚未得到充分讨论。在本研究中,使用过氧乙酸(PAA)和脱氧核糖核酸酶I(DNase I)对大鼠尾动脉(内径0.6毫米)进行脱细胞处理。预计PAA处理不仅会破坏细胞膜,从而提高后续DNase处理中的脱细胞效率,还能对血管支架进行消毒。通过浸入0.3%等渗PAA溶液并随后用DNase溶液洗涤,我们成功实现了充分的细胞去除。对于DNase洗涤过程,灌注法在细胞去除方面优于静态浸泡法。如先前报道,用由胶原结合序列和内皮祖细胞结合序列(Pro-Hyp-Gly)-Gly-Gly-Gly-Arg-Glu-Asp-Val组成的肽对移植血管腔进行修饰。在大鼠同种异体移植模型中,它们在2周内保持通畅,但出乎意料的是,此后出现了移植血管破裂或撕裂形成,这表明脱细胞支架的机械强度降低。组织学显示,通过灌注DNase溶液,细胞外基质(ECM)的厚度减小。PAA和DNase联合使用的方法对于非常细的血管组织的脱细胞处理不一定是最佳的。脱细胞方法是有效去除细胞与维持ECM性质之间的一种折衷。由于宿主组织对ECM变性的可接受性高度依赖于具体情况,应根据目标组织类型及其预期用途仔细选择脱细胞方法。

相似文献

1
Decellularization of submillimeter-diameter vascular scaffolds using peracetic acid.使用过氧乙酸对亚毫米直径血管支架进行去细胞处理。
J Artif Organs. 2020 Jun;23(2):156-162. doi: 10.1007/s10047-019-01152-0. Epub 2020 Jan 1.
2
Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts.用于猪全肝和全肾灌注去细胞化的方法,以用作临床规模生物工程移植物的支架。
Xenotransplantation. 2015 Jan-Feb;22(1):48-61. doi: 10.1111/xen.12141. Epub 2014 Oct 7.
3
Assessment of static and perfusion methods for decellularization of PCL membrane-supported periodontal ligament cell sheet constructs.评估用于脱细胞化 PCL 膜支持的牙周韧带细胞片构建体的静态和灌注方法。
Arch Oral Biol. 2018 Apr;88:67-76. doi: 10.1016/j.archoralbio.2018.01.014. Epub 2018 Jan 31.
4
Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion.使用温和的清洁剂和压力控制灌注快速、稳健且有效地去除整个人类肝脏的细胞。
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110200. doi: 10.1016/j.msec.2019.110200. Epub 2019 Sep 12.
5
Perfusion-decellularization of human ear grafts enables ECM-based scaffolds for auricular vascularized composite tissue engineering.人耳移植物的灌流去细胞化可实现基于细胞外基质的支架用于耳血管化复合组织工程。
Acta Biomater. 2018 Jun;73:339-354. doi: 10.1016/j.actbio.2018.04.009. Epub 2018 Apr 11.
6
Preparation and characterization of small-diameter decellularized scaffolds for vascular tissue engineering in an animal model.用于动物模型血管组织工程的小直径去细胞支架的制备与表征
Biomed Eng Online. 2017 May 11;16(1):55. doi: 10.1186/s12938-017-0344-9.
7
Characterization and in vivo study of decellularized aortic scaffolds using closed sonication system.采用封闭超声系统对脱细胞主动脉支架进行表征和体内研究。
Organogenesis. 2019;15(4):120-136. doi: 10.1080/15476278.2019.1656997. Epub 2019 Sep 7.
8
Evaluation of decellularization protocols for production of tubular small intestine submucosa scaffolds for use in oesophageal tissue engineering.评估脱细胞方案以生产管状小肠黏膜下层支架,用于食管组织工程。
Acta Biomater. 2014 Dec;10(12):5043-5054. doi: 10.1016/j.actbio.2014.08.024. Epub 2014 Aug 27.
9
Novel Sodium Deoxycholate-Based Chemical Decellularization Method for Peripheral Nerve.新型基于脱氧胆酸钠的化学去细胞化方法用于周围神经。
Tissue Eng Part C Methods. 2020 Jan;26(1):23-36. doi: 10.1089/ten.TEC.2019.0135. Epub 2019 Dec 19.
10
Whole Cardiac Tissue Bioscaffolds.全心脏组织生物支架。
Adv Exp Med Biol. 2018;1098:85-114. doi: 10.1007/978-3-319-97421-7_5.

引用本文的文献

1
Enhancing organoid culture: harnessing the potential of decellularized extracellular matrix hydrogels for mimicking microenvironments.增强类器官培养:利用脱细胞细胞外基质水凝胶模拟微环境的潜力。
J Biomed Sci. 2024 Sep 27;31(1):96. doi: 10.1186/s12929-024-01086-7.
2
Cardiac tissue engineering: an emerging approach to the treatment of heart failure.心脏组织工程:治疗心力衰竭的一种新兴方法。
Front Bioeng Biotechnol. 2024 Aug 15;12:1441933. doi: 10.3389/fbioe.2024.1441933. eCollection 2024.
3
Decellularized Matrices for the Treatment of Tissue Defects: from Matrix Origin to Immunological Mechanisms.
用于治疗组织缺损的脱细胞基质:从基质来源到免疫机制
Biomol Ther (Seoul). 2024 Sep 1;32(5):509-522. doi: 10.4062/biomolther.2024.050. Epub 2024 Aug 2.
4
High pressure pasteurization: Simultaneous native tissue decellularization and sterilization.高压巴氏杀菌法:同步实现天然组织去细胞化和灭菌。
Regen Ther. 2024 Feb 8;26:2-8. doi: 10.1016/j.reth.2024.01.012. eCollection 2024 Jun.
5
Extracellular matrix-derived materials for tissue engineering and regenerative medicine: A journey from isolation to characterization and application.用于组织工程和再生医学的细胞外基质衍生材料:从分离到表征及应用的历程。
Bioact Mater. 2024 Jan 17;34:494-519. doi: 10.1016/j.bioactmat.2024.01.004. eCollection 2024 Apr.
6
Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects.用于再生治疗的去细胞细胞外基质生物材料:进展、挑战与临床前景
Bioact Mater. 2023 Oct 4;32:98-123. doi: 10.1016/j.bioactmat.2023.09.017. eCollection 2024 Feb.
7
Intravital tumor decellularization as a new approach to cancer treatment.活体肿瘤去细胞化作为一种癌症治疗的新方法。
Am J Cancer Res. 2023 Sep 15;13(9):4192-4207. eCollection 2023.
8
Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering.用于组织工程的脱细胞细胞外基质的制备与应用
J Funct Biomater. 2022 Nov 14;13(4):240. doi: 10.3390/jfb13040240.
9
Decellularized Extracellular Matrix Scaffolds for Cardiovascular Tissue Engineering: Current Techniques and Challenges.脱细胞细胞外基质支架在心血管组织工程中的应用:当前技术和挑战。
Int J Mol Sci. 2022 Oct 27;23(21):13040. doi: 10.3390/ijms232113040.
10
Decellularized blood vessel development: Current state-of-the-art and future directions.去细胞血管的发展:当前的技术水平与未来方向。
Front Bioeng Biotechnol. 2022 Aug 8;10:951644. doi: 10.3389/fbioe.2022.951644. eCollection 2022.